emocha miDOT

Maunank Shah

Product description Brand name and product description

miDOT is a smartphone-based proxy for Directly Observed Therapy (DOT). miDOT allows patients to securely report side effects and submit videos of themselves taking medication for clinicians to review.

Target region(s) Target region for distribution/implementation (listed by country if specified)

U.S (Maryland, TexasCalifornia), Australia, India

Distributors/implementing organizations Organization(s) distributing/deploying this product directly to communities/individuals?"
Market suggested retail price Price per unit or service price per usage/terms (USD). Subsidies noted.


Competitive landscape Similar products available on the market. May not be a comprehensive listing.
SDG targeted United Nations Sustainable Development Goals (SDGs) targeted with this product/application/service

Provide treatment to over 9 million people worldwide that are infected with tuberculosis. Tuberculosis treatment standards require healthcare workers to directly observe patients taking medication

Target user(s) Target user/consumer base (country, income segment)

TB patients, clinicians.

The @AutodeskFdn blogged about our how-to guide for communities writing proposals for development projects https://t.co/MlRH1H0x2F